NEURONA THERAPEUTICS, INC — Form D/A
NEURONA THERAPEUTICS, INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2022-12-23. The offering totals $91.6M, of which $72.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-23
- Form: D/A
- Accession: 0001443321-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $91.6M
- Amount sold: $72.0M
- Remaining: $19.6M
- Investors: 21
- Date of first sale: 2021-03-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393804
Issuer
- Name: NEURONA THERAPEUTICS, INC
- CIK: 0001443321
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 170 HARBOR WAY, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-676-4182
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Stephen Hauser | Director | South San Francisco, CA |
| Arnold Kriegstein | Director | South San Francisco, CA |
| Tim Kutzkey | Director | South San Francisco, CA |
| Tim Kutzkey | Executive Officer | South San Francisco, CA |
| Peter Svennilson | Director | South San Francisco, CA |
| Brad Margus | Director | South San Francisco, CA |
| Cory Nicholas | Director | South San Francisco, CA |
| Cory Nicholas | Executive Officer | South San Francisco, CA |
| Cory Nicholas | Promoter | South San Francisco, CA |
| James Stutz | Executive Officer | South San Francisco, CA |
| Ray Kelleher | Director | South San Francisco, CA |
| Erica Whittaker | Director | South San Francisco, CA |
| Leo Guthart | Director | South San Francisco, CA |
| Erica Whitaker | Director | South San Francisco, CA |
| Robert Tjian | Director | South San Francisco, CA |
| David Goeddel | Director | Agoura Hills, CA |
| Leo R Guthart | Director | South San Francisco, CA |
| Robert R Tijan | Director | South San Francisco, CA |
| Stephen R Hauser | Director | South San Francisco, CA |
| Arnold R Kriegstein | Director | South San Francisco, CA |
Other filings by this issuer (7)
More